Pharmadons
ActiveSummary
Pharmadons has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €98,180 and a net result of -€9,746. Equity is growing by about 24% per year across the filed financial years. Its solvency ranks better than 27% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Directors
Directors
2 directors, last change in 2024
Board 2
BDM PHARMA
CurrentDirector · since 01-07-2024 · Private limited company · permanent representative: Mélissa DAMTCHOU MBITOM
LAMBERT Stéphane Urbain Henri
CurrentAdministrateurnonstatutaire
Permanent representatives 1
Mélissa DAMTCHOU MBITOM
CurrentPermanent representative · since 01-07-2024 · for BDM PHARMA
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
2 of this company's 4 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
3 people since 2024, 2 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| LAMBERT Stéphane Urbain Henri |
|
| BDM PHARMA |
|
| Stéphane LAMBERT |
|
Owners and capital
Capital and shareholders
Capital over the years
- 19-06-2024 Converted to unavailable equity · €20,460